Consistent with an autocrine function of activin A in the regulation of IL‐6 secretion from the cancer cells, an activin A neutralizing antibody reduced the level of IL‐6 in CMs by 22% from 6.1 ng/mL in untreated cells (Figures3B and S3). The gene discussed is IL6; the disease is cancer.